Abstract
The treatment of proven carriers of Staphylococcus aureus with mupirocin is an effective method to prevent Staphylococcus aureus nosocomial infections after surgery. Cost-analysis studies show that this screen-and-treat approach is cost saving as long as the prevalence of mupirocin resistance in Staphylococcus aureus is low. The effect of chlorhexidine gluconate on the Staphylococcus aureus infection rate in carriers should be determined in future studies.
| Original language | English |
|---|---|
| Pages (from-to) | 380-384 |
| Number of pages | 5 |
| Journal | Current Opinion in Infectious Diseases |
| Volume | 21 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Aug 2008 |
| Externally published | Yes |
Keywords
- Chlorhexidine gluconate
- Infection
- Mupirocin
- Staphylococcus aureus
- Surgery
Fingerprint
Dive into the research topics of 'New approaches to prevention of staphylococcal infection in surgery'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver